Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
WPP
WPP
$5.82B
| $1.43M | ﹤0.01% |
14,253
-17,529
| -55% | -$1.82M |
|
|
UTEK
2902
CALL
DELISTED
Ultratech Inc.
UTEK
| $1.43M | ﹤0.01% |
64,800
-500
| -0.8% | -$12.2K |
|
2903
CALL
Assured Guaranty
AGO
$3.35B
| $1.42M | ﹤0.01% |
64,700
+3,500
| +6% | +$81.4K |
|
2904
RPM International
RPM
$14.5B
| $1.42M | ﹤0.01% |
31,566
-21,791
| -41% | -$1,000K |
|
2905
Myriad Genetics
MYGN
$303M
| $1.42M | ﹤0.01% |
37,379
+11,403
| +44% | +$425K |
|
2906
ServiceNow
NOW
$132B
| $1.42M | ﹤0.01% |
122,605
-1,485
| -1% | -$17.5K |
|
|
ACH
2907
Accendra Health
ACH
$84.6M
| $1.42M | ﹤0.01% |
44,418
-22,386
| -34% | -$762K |
|
2908
CALL
PACCAR
PCAR
$68.8B
| $1.42M | ﹤0.01% |
37,950
-24,000
| -39% | -$1M |
|
|
CPL
2909
DELISTED
CPFL Energia S.A.
CPL
| $1.42M | ﹤0.01% |
99,967
+7,404
| +8% | +$126K |
|
|
AMTD
2910
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.42M | ﹤0.01% |
42,926
-16,320
| -28% | -$528K |
|
2911
Perdoceo Education
PRDO
$1.99B
| $1.42M | ﹤0.01% |
283,175
+36,772
| +15% | +$189K |
|
|
SOHU
2912
CALL
Sohu.com
SOHU
$364M
| $1.42M | ﹤0.01% |
28,300
-6,500
| -19% | -$367K |
|
2913
CALL
iShares Core S&P Small-Cap ETF
IJR
$113B
| $1.41M | ﹤0.01% |
27,200
-8,400
| -24% | -$457K |
|
|
BID
2914
CALL
DELISTED
Sotheby's
BID
| $1.41M | ﹤0.01% |
40,400
-2,800
| -6% | -$110K |
|
|
TLP
2915
DELISTED
Transmontaigne
TLP
| $1.41M | ﹤0.01% |
34,492
+16,467
| +91% | +$711K |
|
2916
Open Text
OTEX
$6.02B
| $1.41M | ﹤0.01% |
51,312
+46,390
| +943% | +$1.24M |
|
2917
Groupon
GRPN
$894M
| $1.41M | ﹤0.01% |
11,764
-8,652
| -42% | -$1.13M |
|
|
CTRX
2918
CALL
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $1.41M | ﹤0.01% |
33,600
-36,700
| -52% | -$1.67M |
|
|
PDLI
2919
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.41M | ﹤0.01% |
201,720
-944
| -0.5% | -$8.76K |
|
2920
PUT
TechnipFMC
FTI
$30.1B
| $1.41M | ﹤0.01% |
35,078
-11,828
| -25% | -$522K |
|
2921
Euronet Worldwide
EEFT
$2.78B
| $1.4M | ﹤0.01% |
29,865
+3,263
| +12% | +$163K |
|
2922
Leidos
LDOS
$17.9B
| $1.4M | ﹤0.01% |
41,240
-4,663
| -10% | -$172K |
|
|
SC
2923
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.4M | ﹤0.01% |
82,500
| – | – |
|
2924
Dynagas LNG Partners
DLNG
$138M
| $1.4M | ﹤0.01% |
60,925
+55,469
| +1,017% | +$1.32M |
|
2925
CALL
Newell Brands
NWL
$2.63B
| $1.4M | ﹤0.01% |
41,200
+31,900
| +343% | +$1.05M |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.